Sobrevida de mulheres com câncer de mama subtipo luminal assistidas em Juiz de Fora, Minas Gerais, Brasil
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora
DOI
Abstract
Luminal breast cancer usually has a better prognosis in relation to other tumoral
subtypes. Nonetheless, the illness in this point can evolve unfavorably in some
circumstances what signals the need for a better understanding about this
tumoral subtype behavior. The present study aimed at estimating the diseasefree
survival of women with luminal breast cancer in five years. In this study,
many variables have been evaluated, including prognostic, clinic,
sociodemographic, histopathological and related to the use of public health
services and treatment, aiming to get to know their impact and implications on
recurrence and survival among the population of the study. The database was a
hospital based cohort study, composed of 331 women diagnosed with the
disease between 2003 and 2005, with immunohistochemical profile compatible
with luminal breast cancer, non-metastatic (stages I, II or III), treated in a
hospital seen as a reference for cancer care in Juiz de Fora, MG. The study
showed a disease-free survival of 79.5% (IC95%: 74.6-83.6) in five years. The
univariate analysis has shown an association of tumor recurrence with the type
of health care, staging, tumor size, lymph node involvement and their number,
chemotherapy and hormonal therapy (p<0.05) and it has indicated better
survival rates among women who used private health care, who are in an initial
stage, with smaller tumors, no axillary involvement and who used hormonal
therapy. In the multivariate model, there remained gravity of the illness and the
use of hormonal therapy as the most important prognostic factors. Molecular
biology techniques represent the future for cancer treatment and also for
luminal tumors. Access to hormonal therapy should be granted whenever
prescribed and advanced stages must receive an amplified range of therapeutic
approach.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
